SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Stock Repurchases, Incentives Suggested for Company
Rumblings of change may be in store for Volcano Corp., now that an activist investor has acquired 5.1 percent of the San Diego-based medical device maker’s shares.
Biotechnology/Health Care Column
The CEO of a local stem cell company who I spoke with recently joked that UCSD — as the University of California, San Diego used to abbreviate its name before it adopted the short form UC San Diego — should be renamed as UCDS. That would stand for the University of California-Denny Sanford.
Santarus Inc., a San Diego maker of diabetes and gastrointestinal drugs, has agreed to be acquired for $2.6 billion by Salix Pharmaceuticals Ltd.
San Diego-based Acadia Pharmaceuticals Inc. reported a net loss of $10.7 million in its third quarter earnings this year — an increase from its $2.4 million loss in the third quarter of 2012.
San Diego’s Sophiris Bio Inc. has applied for a voluntary delisting from the Toronto Stock Exchange.
San Diego-based Tandem Diabetes Care Inc. has set the terms for its $100 million IPO, offering 7.1 million shares at a price of $13 to $15.
San Diego-based Cytori Therapeutics Inc. could receive as much as $531 million in an Asia Pacific licensing deal with Chinese regenerative medicine company Lorem Vascular.
Businessman and philanthropist T. Denny Sanford has committed $100 million to create the Sanford Stem Cell Clinical Center at University of California, San Diego.
Right on the heels of the Food and Drug Administration’s approval of the narcotic painkiller Zohydro, San Diego-based Zogenix Inc. has announced a $60 million public offering of its stock.
San Diego-based drugmaker Celladon Corp. announced the terms of its approximately $75 million initial public offering, with plans to release 5 million shares of stock at a price range of $14 to $16 per share.
MEDICINE: It Will Focus on Improving Stakeholders’ Experiences
Tri-City Medical Center is regrouping after the firing of its chief executive, Larry Anderson, with Chief Operating Officer Casey Fatch filling the position in the interim.
PHARMA: Many at Co. Have A ‘Rich History’
Seragon Pharmaceuticals Inc. — a new San Diego company focused on breast cancer therapies with a management team coming off an extremely lucrative exit — has raised $30 million in Series A financing.
Biotech/Health Care Column
Illumina Inc. has acquired Silicon Valley-based NextBio Inc., which uses big data technology to systematically catalogue and interpret genetic data. This is a notable move for a company like Illumina that has a vested stake in lowering the cost of sequencing the human genome.
HEALTH: DJO Sees Aging Population Needing Its Devices to Stay Mobile
Vista-based DJO Global Inc.’s DonJoy brand has minor celebrity status in the football circuit, with its knee braces making regular cameos on national television.
HEALTH: Project Finished Ahead of Schedule and $100 Million Under Budget
Six months ahead of schedule and more than $100 million under budget, the joint-venture team of Clark Construction Group LLC and McCarthy Building Cos. Inc. is putting the finishing touches on a $456 million naval hospital at Marine Corps Base Camp Pendleton.